Nucleoprotein 396-404
CAS No. 158475-79-7
Nucleoprotein 396-404( NP 396 )
Catalog No. M29777 CAS No. 158475-79-7
Nucleoprotein (396-404) is the 396 to 404 fragment of lymphocytic choriomeningitis virus (LCMV). Nucleoprotein (396-404) is the H-2D(b)-restricted immunodominant epitope and can be used as a molecular model of viral antigen.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 259 | Get Quote |
|
| 10MG | 365 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameNucleoprotein 396-404
-
NoteResearch use only, not for human use.
-
Brief DescriptionNucleoprotein (396-404) is the 396 to 404 fragment of lymphocytic choriomeningitis virus (LCMV). Nucleoprotein (396-404) is the H-2D(b)-restricted immunodominant epitope and can be used as a molecular model of viral antigen.
-
DescriptionNucleoprotein (396-404) is the 396 to 404 fragment of lymphocytic choriomeningitis virus (LCMV). Nucleoprotein (396-404) is the H-2D(b)-restricted immunodominant epitope and can be used as a molecular model of viral antigen.
-
In Vitro——
-
In Vivo——
-
SynonymsNP 396
-
PathwayMicrobiology/Virology
-
TargetArenavirus
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number158475-79-7
-
Formula Weight1078.18
-
Molecular FormulaC50H71N13O14
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (92.75 mM)
-
SMILES——
-
Chemical NameSequence:Phe-Gln-Pro-Gln-Asn-Gly-Gln-Phe-Ile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Glycoprotein 276-286
Known Db-restricted peptide of lymphocytic choriomeningitis virus (LCMV).
-
LASV inhibitor 3.3
LASV inhibitor 3.3 (LAMP1 inhibitor 3.3) is a specific inhibitor of Lassa fever virus (LASV, IC50=1.8 uM).
-
ST-193
ST-193 (ST193) is a potent, selective, broad-spectrum arenavirus entry inhibitor with IC50 of 1.6 nM against LASV pseudotypes, targets arenavirus envelope glycoprotein.
Cart
sales@molnova.com